What are the major opportunities in the Rheumatic Heart Disease market? What are the strategies for the Rheumatic Heart Disease market?

For detailed insights on the major opportunities and strategies in the Rheumatic Heart Disease market, Read More

How does the Rheumatic Heart Disease market relate to the overall economy and other similar markets?

For detailed insights on Rheumatic Heart Disease's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Rheumatic Heart Disease market growth? SWOT analysis of the Rheumatic Heart Disease market.

For detailed insights on the key dynamics influencing the Rheumatic Heart Disease market growth and SWOT analysis of the Rheumatic Heart Disease industry, Read More

Rheumatic Heart Disease Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Rheumatic Heart Disease Market Report 2026

Name: Rheumatic Heart Disease Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Valve, Myocarditis, Pericarditis), By Age Group (Pediatric, Adolescent, Adult, Geriatric), By Application (Hospital, Diagnostic Centre, Research Centre), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Rheumatic Heart Disease Market Overview

• Rheumatic Heart Disease market size has reached to $2.71 billion in 2025

• Expected to grow to $3.6 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%

• Growth Driver: Rising Prevalence of Strep Throat Driving The Growth Of The Market Due To Increasing Infection Rates And Antibiotic Resistance

• Market Trend: Strengthening Healthcare Access Through Public-Private Partnerships For Early Disease Detection And Treatment

• North America was the largest region in 2025.

What Is Covered Under Rheumatic Heart Disease Market?

Rheumatic heart disease (RHD) is a chronic heart condition caused by permanent damage to the heart valves due to rheumatic fever, an inflammatory disease resulting from untreated or inadequately treated streptococcal throat infections. The immune response triggered by the infection leads to inflammation and scarring of the heart valves, impairing their function and potentially causing heart failure, arrhythmias, or other complications.

The main types of rheumatic heart disease include valve-related disease, myocarditis, and pericarditis. Valve-related rheumatic heart disease occurs when rheumatic fever damages the heart valves, leading to impaired blood flow and complications such as stenosis or regurgitation. The impacted age groups encompass pediatric, adolescent, adult, and geriatric populations. Rheumatic heart disease is addressed and treated across multiple applications, such as hospitals, diagnostic centers, and research centers. The distribution channels for drugs include hospital pharmacies, retail pharmacies, online pharmacies, and direct sales.

Rheumatic Heart Disease Market Global Report 2026 Market Report bar graph

What Is The Rheumatic Heart Disease Market Size and Share 2026?

The rheumatic heart disease market size has grown strongly in recent years. It will grow from $2.71 billion in 2025 to $2.88 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to high prevalence of untreated streptococcal infections, limited access to early healthcare in developing regions, historical burden of rheumatic fever, dependence on clinical diagnosis methods, constrained availability of advanced cardiac care.

What Is The Rheumatic Heart Disease Market Growth Forecast?

The rheumatic heart disease market size is expected to see strong growth in the next few years. It will grow to $3.6 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing investments in public health screening programs, rising adoption of digital cardiac diagnostics, growing awareness of early intervention benefits, expansion of cardiac surgical infrastructure, increased focus on disease prevention strategies. Major trends in the forecast period include increasing adoption of early diagnostic screening programs, rising use of echocardiography and imaging tools, growing focus on preventive antibiotic therapies, expansion of valve repair and replacement procedures, enhanced monitoring of pediatric and adolescent patients.

Book your 30 minutes free consultation with our research experts

Global Rheumatic Heart Disease Market Segmentation

1) By Type: Valve, Myocarditis, Pericarditis

2) By Age Group: Pediatric, Adolescent, Adult, Geriatric

3) By Application: Hospital, Diagnostic Centre, Research Centre

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales

Subsegments:

1) By Valve: Mitral Valve Disease, Aortic Valve Disease, Tricuspid Valve Disease, Pulmonary Valve Disease

2) By Myocarditis: Acute Myocarditis, Chronic Myocarditis, Fulminant Myocarditis

3) By Pericarditis: Acute Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Effusive Pericarditis

What Is The Driver Of The Rheumatic Heart Disease Market?

The increasing prevalence of strep throat is expected to propel the growth of the rheumatic heart disease market going forward. Strep throat refers to a bacterial infection caused by streptococcus pyogenes (group a streptococcus) it leads to inflammation and pain in the throat, often accompanied by fever, swollen lymph nodes, and difficulty swallowing. Rising antibiotic resistance is making streptococcal infections harder to treat effectively, which leads to prolonged illness and higher transmission rates in communities. Rheumatic heart disease develops as a long-term complication of untreated or recurrent strep throat infections, highlighting the importance of early diagnosis and treatment of streptococcal infections to prevent severe heart damage. For instance, in April 2023, according to the Centers for Disease Control and Prevention, a US-based government department, strep throat accounts for an estimated 5.2 million outpatient visits annually among individuals younger than 65 years old. These visits lead to 2.8 million antibiotic prescriptions each year. Therefore, the increasing prevalence of strep throat is driving the growth of the rheumatic heart disease industry.

Key Players In The Global Rheumatic Heart Disease Market

Major companies operating in the rheumatic heart disease market are Pfizer Inc., Merck And Co Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc, Medtronic plc, Siemens Healthineers AG, Becton Dickinson And Company, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Medanta, Johnson And Johnson Services Inc., Roche Holding AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Boehringer Ingelheim International GmbH, Edwards Lifesciences Corporation

Global Rheumatic Heart Disease Market Trends and Insights

Major companies operating in the rheumatic heart disease market are adopting a strategic partnership approach to develop innovative treatments and diagnoses. Strategic partnerships in the rheumatic heart disease (RHD) management unite resources and expertise to advance research and development, enhance diagnostic and therapeutic innovations, expand market penetration, and fast-track commercialization. For instance, in July 2023, the World Heart Federation (WHF), a Switzerland-based non-governmental organization, partnered with the Philips Foundation, a Netherlands-based nonprofit organization, to improve awareness, medical training, and early detection of rheumatic heart disease (RHD) in the Asia-Pacific (APAC) region. Launched in the Philippines, the initiative seeks to enhance healthcare access for over half a million at-risk Filipino children by equipping facilities with trained professionals and advanced diagnostic tools. This collaboration underscores a joint commitment to strengthening healthcare infrastructure and ensuring timely intervention for RHD patients.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Rheumatic Heart Disease Market?

In February 2025, Light AI Inc., a Canada-based healthcare technology company, partnered with MrBeast Industries to support global health initiatives. This collaboration focuses on donating AI-powered Strep A tests across Africa, enabling early detection and prevention of the disease to reduce the risk of severe complications such as rheumatic heart disease. MrBeast Industries is a US-based media and entertainment company that focuses on digital content creation.

Regional Outlook

North America was the largest region in the rheumatic heart disease market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Rheumatic Heart Disease Market?

The rheumatic heart disease market consists of revenues earned by entities by providing services such as surgical treatments, diagnostic tests, preventive care services, and pediatric care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The rheumatic heart disease market also includes sales of antibiotics, anti-inflammatory medications, diuretics, beta-blockers, and ACE inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Rheumatic Heart Disease Market Report 2026?

The rheumatic heart disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rheumatic heart disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Rheumatic Heart Disease Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.88 billion
Revenue Forecast In 2035	$3.6 billion
Growth Rate	CAGR of 6.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Age Group, Application, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Merck And Co Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc, Medtronic plc, Siemens Healthineers AG, Becton Dickinson And Company, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Medanta, Johnson And Johnson Services Inc., Roche Holding AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Boehringer Ingelheim International GmbH, Edwards Lifesciences Corporation
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Rheumatic Heart Disease Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Rheumatic Heart Disease Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Rheumatic Heart Disease Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Rheumatic Heart Disease Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Adoption Of Early Diagnostic Screening Programs

4.2.2 Rising Use Of Echocardiography And Imaging Tools

4.2.3 Growing Focus On Preventive Antibiotic Therapies

4.2.4 Expansion Of Valve Repair And Replacement Procedures

4.2.5 Enhanced Monitoring Of Pediatric And Adolescent Patients

5. Rheumatic Heart Disease Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Centres

5.3 Cardiac Care Clinics

5.4 Research Centres

5.5 Specialty Cardiology Institutes

6. Rheumatic Heart Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Rheumatic Heart Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Rheumatic Heart Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Rheumatic Heart Disease Market Size, Comparisons And Growth Rate Analysis

7.3. Global Rheumatic Heart Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Rheumatic Heart Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Rheumatic Heart Disease Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Rheumatic Heart Disease Market Segmentation

9.1. Global Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Valve, Myocarditis, Pericarditis

9.2. Global Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric, Adolescent, Adult, Geriatric

9.3. Global Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Diagnostic Centre, Research Centre

9.4. Global Rheumatic Heart Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales

9.5. Global Rheumatic Heart Disease Market, Sub-Segmentation Of Valve, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mitral Valve Disease, Aortic Valve Disease, Tricuspid Valve Disease, Pulmonary Valve Disease

9.6. Global Rheumatic Heart Disease Market, Sub-Segmentation Of Myocarditis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acute Myocarditis, Chronic Myocarditis, Fulminant Myocarditis

9.7. Global Rheumatic Heart Disease Market, Sub-Segmentation Of Pericarditis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acute Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Effusive Pericarditis

10. Rheumatic Heart Disease Market Regional And Country Analysis

10.1. Global Rheumatic Heart Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Rheumatic Heart Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Rheumatic Heart Disease Market

11.1. Asia-Pacific Rheumatic Heart Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Rheumatic Heart Disease Market

12.1. China Rheumatic Heart Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Rheumatic Heart Disease Market

13.1. India Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Rheumatic Heart Disease Market

14.1. Japan Rheumatic Heart Disease Market Overview

14.2. Japan Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Rheumatic Heart Disease Market

15.1. Australia Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Rheumatic Heart Disease Market

16.1. Indonesia Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Rheumatic Heart Disease Market

17.1. South Korea Rheumatic Heart Disease Market Overview

17.2. South Korea Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Rheumatic Heart Disease Market

18.1. Taiwan Rheumatic Heart Disease Market Overview

18.2. Taiwan Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Rheumatic Heart Disease Market

19.1. South East Asia Rheumatic Heart Disease Market Overview

19.2. South East Asia Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Rheumatic Heart Disease Market

20.1. Western Europe Rheumatic Heart Disease Market Overview

20.2. Western Europe Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Rheumatic Heart Disease Market

21.1. UK Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Rheumatic Heart Disease Market

22.1. Germany Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Rheumatic Heart Disease Market

23.1. France Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Rheumatic Heart Disease Market

24.1. Italy Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Rheumatic Heart Disease Market

25.1. Spain Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Rheumatic Heart Disease Market

26.1. Eastern Europe Rheumatic Heart Disease Market Overview

26.2. Eastern Europe Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Rheumatic Heart Disease Market

27.1. Russia Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Rheumatic Heart Disease Market

28.1. North America Rheumatic Heart Disease Market Overview

28.2. North America Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Rheumatic Heart Disease Market

29.1. USA Rheumatic Heart Disease Market Overview

29.2. USA Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Rheumatic Heart Disease Market

30.1. Canada Rheumatic Heart Disease Market Overview

30.2. Canada Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Rheumatic Heart Disease Market

31.1. South America Rheumatic Heart Disease Market Overview

31.2. South America Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Rheumatic Heart Disease Market

32.1. Brazil Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Rheumatic Heart Disease Market

33.1. Middle East Rheumatic Heart Disease Market Overview

33.2. Middle East Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Rheumatic Heart Disease Market

34.1. Africa Rheumatic Heart Disease Market Overview

34.2. Africa Rheumatic Heart Disease Market, Segmentation By Type, Segmentation By Age Group, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Rheumatic Heart Disease Market Regulatory and Investment Landscape

36. Rheumatic Heart Disease Market Competitive Landscape And Company Profiles

36.1. Rheumatic Heart Disease Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Rheumatic Heart Disease Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Rheumatic Heart Disease Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck And Co Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

37. Rheumatic Heart Disease Market Other Major And Innovative Companies

Novartis AG, Abbott Laboratories, GlaxoSmithKline plc, Medtronic plc, Siemens Healthineers AG, Becton Dickinson And Company, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Medanta, Johnson And Johnson Services Inc., Roche Holding AG, Bristol Myers Squibb Company

38. Global Rheumatic Heart Disease Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Rheumatic Heart Disease Market

40. Rheumatic Heart Disease Market High Potential Countries, Segments and Strategies

40.1 Rheumatic Heart Disease Market In 2030 - Countries Offering Most New Opportunities

40.2 Rheumatic Heart Disease Market In 2030 - Segments Offering Most New Opportunities

40.3 Rheumatic Heart Disease Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Rheumatic Heart Disease Market, Overview Of Key Products - Product Examples

Table 2: Global Rheumatic Heart Disease Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Rheumatic Heart Disease Market, Supply Chain Analysis

Table 4: Global Rheumatic Heart Disease Market, Major Raw Material Providers

Table 5: Global Rheumatic Heart Disease Market, Major Resource Providers

Table 6: Global Rheumatic Heart Disease Market, Major Manufacturers (Suppliers)

Table 7: Global Rheumatic Heart Disease Market, Major Distributors And Channel Partners

Table 8: Global Rheumatic Heart Disease Market, Key Technologies & Future Trends

Table 9: Global Rheumatic Heart Disease Market, Major Trends

Table 10: Global Rheumatic Heart Disease Market, Major End Users

Table 11: Global Rheumatic Heart Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Rheumatic Heart Disease Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Rheumatic Heart Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Rheumatic Heart Disease Market - TAM, US$ Billion, 2025

Table 15: Global Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Rheumatic Heart Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Valve, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Myocarditis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Pericarditis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Rheumatic Heart Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Rheumatic Heart Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Rheumatic Heart Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Rheumatic Heart Disease Market - Company Scoring Matrix

Table 98: Pfizer Inc. Financial Performance

Table 99: Merck And Co Inc. Financial Performance

Table 100: Bayer AG Financial Performance

Table 101: Sanofi SA Financial Performance

Table 102: AstraZeneca plc Financial Performance

Table 103: Global Rheumatic Heart Disease Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Rheumatic Heart Disease Market, Competitive Dashboard

Table 105: Global Rheumatic Heart Disease Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Rheumatic Heart Disease Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Rheumatic Heart Disease Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Table 108: Global, Rheumatic Heart Disease Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Rheumatic Heart Disease Market, Overview Of Key Products - Product Examples

Figure 2: Global Rheumatic Heart Disease Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Rheumatic Heart Disease Market, Supply Chain Analysis

Figure 4: Global Rheumatic Heart Disease Market, Major Raw Material Providers

Figure 5: Global Rheumatic Heart Disease Market, Major Resource Providers

Figure 6: Global Rheumatic Heart Disease Market, Major Manufacturers (Suppliers)

Figure 7: Global Rheumatic Heart Disease Market, Major Distributors And Channel Partners

Figure 8: Global Rheumatic Heart Disease Market, Key Technologies & Future Trends

Figure 9: Global Rheumatic Heart Disease Market, Major Trends

Figure 10: Global Rheumatic Heart Disease Market, Major End Users

Figure 11: Global Rheumatic Heart Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Rheumatic Heart Disease Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Rheumatic Heart Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Rheumatic Heart Disease Market - TAM, US$ Billion, 2025

Figure 15: Global Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Rheumatic Heart Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Valve, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Myocarditis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Rheumatic Heart Disease Market, Sub-Segmentation Of Pericarditis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Rheumatic Heart Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Rheumatic Heart Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Rheumatic Heart Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Rheumatic Heart Disease Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Rheumatic Heart Disease Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Rheumatic Heart Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Rheumatic Heart Disease Market - Company Scoring Matrix

Figure 98: Pfizer Inc. Financial Performance

Figure 99: Merck And Co Inc. Financial Performance

Figure 100: Bayer AG Financial Performance

Figure 101: Sanofi SA Financial Performance

Figure 102: AstraZeneca plc Financial Performance

Figure 103: Global Rheumatic Heart Disease Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Rheumatic Heart Disease Market, Competitive Dashboard

Figure 105: Global Rheumatic Heart Disease Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Rheumatic Heart Disease Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Rheumatic Heart Disease Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Figure 108: Global, Rheumatic Heart Disease Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Heart Attack Diagnostic Market Report 2026 - Global Outlook – By Test Type (Electrocardiogram (ECG Or EKG), Blood Tests, Echocardiogram, Coronary Catheterization (Angiogram)), By Procedure (Invasive Procedure, Non-Invasi...

Peripheral Artery Disease Market Report 2026 - Global Outlook – By Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynami...

Peripheral Arterial Disease Market Report 2026 - Global Outlook – By Treatment Type (Devices, Catheters, Drugs, Other Types), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By End User (Ho...

Cardiac Valve Market Report 2026 - Global Outlook – By Type (Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves), By Position (Aortic Valve, Mitral Valve, Other Positions), By Treatment (Cardiac Val...

Coronary Artery Disease Market Report 2026 - Global Outlook – By Treatment (Medication, Surgery, Additional Therapy, Other Treatments), By Diagnosis (Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterizatio...

Congenital Heart Disease (CHD) Market Report 2026 - Global Outlook – By Type (Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types), By Diagnosis (Electrocardiogram, Chest X-ray, Echocardiogram, Tr...

Pericarditis Market Report 2026 - Global Outlook – By Type (Acute Pericarditis, Chronic Pericarditis, Recurrent Pericarditis), By Diagnosis And Treatment (Electrocardiogram (ECG), Echocardiogram, Computerized Tomography ...

Frequently Asked Questions

How big is the Rheumatic Heart Disease Market?

The Rheumatic Heart Disease market was valued at $2.71 billion in 2025, increased to $2.88 billion in 2026, and is projected to reach $3.6 billion by 2030.

What is the Rheumatic Heart Disease market growth?

The global Rheumatic Heart Disease market is expected to grow at a CAGR of 5.8% from 2026 to 2035 to reach $3.6 billion by 2035.

Who are the key players in Rheumatic Heart Disease market?

Some Key Players in the Rheumatic Heart Disease market Include, Pfizer Inc., Merck And Co Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc, Medtronic plc, Siemens Healthineers AG, Becton Dickinson And Company, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Medanta, Johnson And Johnson Services Inc., Roche Holding AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Boehringer Ingelheim International GmbH, Edwards Lifesciences Corporation .

What is the anticipated growth trend for the Rheumatic Heart Disease market?

Major trend in this market includes: Strengthening Healthcare Access Through Public-Private Partnerships For Early Disease Detection And Treatment. For further insights on this market. request a sample here

Which region has the most growth potential in the Rheumatic Heart Disease market?

North America was the largest region in the rheumatic heart disease market in 2025. The regions covered in the rheumatic heart disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.